Smoothened gene alterations in keratocystic odontogenic tumors

Head and Face Medicine

Volumn 10, Issue 1, 2014, Pages

  Rui, Zhang ^a   Li Ying, Peng ^a   Jia Fei, Qu ^a   Ying Ying, Hong ^a   Feng, Chen ^a   Tie Jun, Li ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

Gene mutation; Hedgehog (HH) signaling pathway; Keratocystic odontogenic tumor (KCOT); SMO gene

Indexed keywords

DNA; G PROTEIN COUPLED RECEPTOR; SMO PROTEIN, HUMAN;

ADOLESCENT; ADULT; BASAL CELL CARCINOMA; CHILD; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; ODONTOGENIC TUMOR; PATHOLOGY; POLYMERASE CHAIN REACTION; YOUNG ADULT;

ADOLESCENT; ADULT; CARCINOMA, BASAL CELL; CHILD; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; ODONTOGENIC TUMORS; POLYMERASE CHAIN REACTION; RECEPTORS, G-PROTEIN-COUPLED; YOUNG ADULT;

EID: 84907392953     PISSN: None     EISSN: 1746160X     Source Type: Journal    
DOI: 10.1186/1746-160X-10-36     Document Type: Article

References (47)

1. Bhargava D, Deshpande A, Pogrel MA. Keratocystic odontogenic tumour (KCOT)-a cyst to a tumour. Oral Maxillofac Surg 2012, 16(2):163-170.
2. Nayak MT, Singh A, Singhvi A, Sharma R. Odontogenic keratocyst: what is in the name?. J Nat Sc Biol Med 2013, 4(2):282-285.
3. Li TJ. The odontogenic keratocyst: a cyst, or a cystic neoplasm?. J Dent Res 2011, 90(2):133-142.
4. Gu XM, Zhao HS, Sun LS, Li TJ. PTCH mutations in sporadic and gorlin-syndrome-related odontogenic keratocysts. J Dent Res 2006, 85(9):859-863.
5. Guo YY, Zhang JY, Li XF, Luo HY, Chen F, Li TJ. PTCH1 gene mutations in keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review. PLoS ONE 2013, 8(10):e77305.
6. Pan S, Dong Q, Sun LS, Li TJ. Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis. Clin Cancer Res 2010, 16(2):442-450.
7. Li TJ, Yuan JW, Gu XM, Sun LS, Zhao HS. PTCH germline mutations in Chinese nevoid basal cell carcinoma syndrome patients. Oral Dis 2008, 14(2):174-179.
8. Musani V, Sabol M, Car D, Ozretic P, Kalafatic D, Maurac I, Oreskovic S, Levanat S. PTCH1 gene polymorphisms in ovarian tumors: potential protective role of c.3944T allele. Gene 2013, 517(1):55-59.
9. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996, 85(6):841-851.
10. Stone DM, Hynes M, Armanini M, Swanson TA, Gu Q, Johnson RL, Scott MP, Pennica D, Goddard A, Phillips H, Noll M, Hooper JE, de Sauvage F, Rosenthal A. The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 1996, 384(6605):129-134.
11. Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, Ligon KL, Palescandolo E, Van Hummelen P, Ducar MD, Raza A, Sunkavalli A, Macconaill LE, Stemmer-Rachamimov AO, Louis DN, Hahn WC, Dunn IF, Beroukhim R. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 2013, 45(3):285-289.
12. Wang C, Wu H, Katritch V, Han GW, Huang XP, Liu W, Siu FY, Roth BL, Cherezov V, Stevens RC. Structure of the human smoothened receptor bound to an antitumour agent. Nature 2013, 497(7449):338-343.
13. Ruat M, Hoch L, Faure H, Rognan D. Structure of the smoothened receptor. Med Sci 2013, 29(10):855-860.
14. Jiang J, Hui CC. Hedgehog signaling in development and cancer. Dev Cell 2008, 15(6):801-812.
15. Amakye D, Jagani Z, Dorsch M. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat Med 2013, 19(11):1410-1422.
16. Yang W, Wang J, Moore DC, Liang H, Dooner M, Wu Q, Terek R, Chen Q, Ehrlich MG, Quesenberry PJ, Neel BG. Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling. Nature 2013, 499(7459):491-495.
17. Ren Y, Cowan RG, Migone FF, Quirk SM. Overactivation of hedgehog signaling alters development of the ovarian vasculature in mice. Biol Reprod 2012, 86(6):174.
18. Jorgensen TJ, Ruczinski I, Yao Shugart Y, Wheless L, Berthier Schaad Y, Kessing B, Hoffman-Bolton J, Helzlsouer KJ, Kao WH, Francis L, Alani RM, Strickland PT, Smith MW, Alberg AJ. A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer. Cancer Epidemiol 2012, 36(5):e288-e293.
19. Yang C, Chen W, Chen Y, Jiang J. Smoothened transduces Hedgehog signal by forming a complex with Evc/Evc2. Cell Res 2012, 22(11):1593-1604.
20. Shen F, Cheng L, Douglas AE, Riobo NA, Manning DR. Smoothened is a fully competent activator of the heterotrimeric G protein G(i). Mol Pharmacol 2013, 83(3):691-697.
21. Myers BR, Sever N, Chong YC, Kim J, Belani JD, Rychnovsky S, Bazan JF, Beachy PA. Hedgehog pathway modulation by multiple lipid binding sites on the smoothened effector of signal response. Dev Cell 2013, 26(4):346-357.
22. Mao J, Fan PH, Ma W, Zhang QQ, Wang B, Fan SJ, Li LH. Down-regulation of Smoothened gene expression inhibits proliferation of breast cancer stem cells. Zhonghua Bing Li Xue Za Zhi / Chinese Journal of Pathology 2013, 42(4):262-266.
23. Ruat M, Hoch L, Faure H, Rognan D. Targeting of Smoothened for therapeutic gain. Trends Pharmacol Sci 2014, 35(5):237-246.
24. Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J 2006, 85(2):74.
25. Sun LS, Li XF, Li TJ. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors. J Dent Res 2008, 87(6):575-579.
26. Zhang X, Harrington N, Moraes RC, Wu MF, Hilsenbeck SG, Lewis MT. Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo). Breast Cancer Res Treat 2009, 115(3):505-521.
27. Zhang L, Sun ZJ, Chen XM, Chen Z. Immunohistochemical expression of SHH, PTC, SMO and GLI1 in glandular odontogenic cysts and dentigerous cysts. Oral Dis 2010, 16(8):818-822.
28. Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S, Odegaard JI, Sugiyama T, Koyota S, Rubin BP, Troxell ML, Pelham RJ, Zehnder JL, Beachy PA, Pollack JR, West RB. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet 2014, 46(7):722-5.
29. Genetic mutations predict SMO inhibitor response in SHH medulloblastoma. Canc discov 2014, 4(5):509.
30. Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, Avsar T, Li J, Murray PB, Henegariu O, Yilmaz S, Günel JM, Carrión-Grant G, Yilmaz B, Grady C, Tanrikulu B, Bakircioğlu M, Kaymakçalan H, Caglayan AO, Sencar L, Ceyhun E, Atik AF, Bayri Y, Bai H, Kolb LE, Hebert RM, Omay SB, Mishra-Gorur K, Choi M, Overton JD, Holland EC, et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 2013, 339(6123):1077-1080.
31. Kunkalla KLY, Qu C, Leventaki V, Agarwal NK, Singh RR, Vega F. Functional inhibition of BCL2 is needed to increase the susceptibility to apoptosis to SMO inhibitors in diffuse large B-cell lymphoma of germinal center subtype. Ann Hematol 2013, 92:777-787.
32. Xiao BY, Dang H, Gan JY, Cai Q, Zhang GP, Chang H. Expression of PTCH-1 and SMO mRNA in nasopharyngeal carcinoma. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2010, 26(10):955-958.
33. Alcedo J, Ayzenzon M, Von Ohlen T, Noll M, Hooper JE. The Drosophila smoothened gene encodes a seven-pass membrane protein, a putative receptor for the hedgehog signal. Cell 1996, 86(2):221-232.
34. Levanat S, Kappler R, Hemmerlein B, Doring P, Musani V, Komar A, Oreskovic S, Pavelic B, Hahn H. Analysis of the PTCH1 signaling pathway in ovarian dermoids. Int J Mol Med 2004, 14(5):793-799.
35. Honma M, Ohishi Y, Uehara J, Ibe M, Kinouchi M, Ishida-Yamamoto A, Iizuka H. A novel PTCH1 mutation in a patient of nevoid basal cell carcinoma syndrome. J Dermatol Sci 2008, 50(1):73-75.
36. Hime GR, Lada H, Fietz MJ, Gillies S, Passmore A, Wicking C, Wainwright BJ. Functional analysis in Drosophila indicates that the NBCCS/PTCH1 mutation G509V results in activation of smoothened through a dominant-negative mechanism. Dev Dyn 2004, 229(4):780-790.
37. Hu J, Ng PC. SIFT indel: predictions for the functional effects of amino acid insertions/deletions in proteins. PLoS ONE 2013, 8(10):e77940.
38. Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, et al. CDD: a conserved domain database for the functional annotation of proteins. Nucleic Acids Res 2011, 39(Database issue):D225-D229.
39. Marchler-Bauer A, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Liebert CA, Liu C, Lu F, Lu S, Marchler GH, Mullokandov M, Song JS, Tasneem A, Thanki N, Yamashita RA, Zhang D, Zhang N, Bryant SH. CDD: specific functional annotation with the conserved domain database. Nucleic Acids Res 2009, 37(Database issue):D205-D210.
40. Marchler-Bauer A, Bryant SH. CD-Search: protein domain annotations on the fly. Nucleic Acids Res 2004, 32(Web Server issue):W327-W331.
41. Cleary AS, Leonard TL, Gestl SA, Gunther EJ. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature 2014, 508(7494):113-117.
42. Lim CB, Prele CM, Cheah HM, Cheng YY, Klebe S, Reid G, Watkins DN, Baltic S, Thompson PJ, Mutsaers SE. Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. PLoS ONE 2013, 8(6):e66685.
43. Candace E, Carroll SM, Stewart DP, Xiaoxi Ouyang J, Ogden SK. The extracellular loops of Smoothened play a regulatory role in control of Hedgehog pathway activation. Development 2012, 139(3):612-621.
44. Teng X, Dayhoff-Brannigan M, Cheng WC, Gilbert CE, Sing CN, Diny NL, Wheelan SJ, Dunham MJ, Boeke JD, Pineda FJ, Hardwick JM. Genome-wide consequences of deleting any single gene. Mol Cell 2013, 52(4):485-494.
45. Onishi H, Katano M. Hedgehog signaling pathway as a therapeutic target in various types of cancer. Cancer Sci 2011, 102(10):1756-1760.
46. Abidi A. Hedgehog signaling pathway: a novel target for cancer therapy: vismodegib, a promising therapeutic option in treatment of basal cell carcinomas. Indian J Pharmacol 2014, 46(1):3-12.
47. Matsushita S, Onishi H, Nakano K, Nagamatsu I, Imaizumi A, Hattori M, Oda Y, Tanaka M, Katano M. Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer. Cancer Sci 2014, 105(3):272-280.